GlaxoSmithKline uses clinical graphics solution developed by Insightful Corporation
Insightful Corporation, a leading provider of predictive analytics and reporting solutions, announced today that GlaxoSmithKline, one of the world's leading research-based pharmaceutical and healthcare companies, is using a clinical graphics solution developed by Insightful and S-PLUS ® , Insightful's software platform for statistical data analysis and predictive analytics, to speed the design, analysis, and reporting of clinical trial data.
British drugmaker GlaxoSmithKline used a sophisticated ghostwriting program to promote its antidepressant Paxil, allowing doctors to take credit for medical journal articles mainly written by company consultants, according to court documents obtained by The Associated Press.